Name | Number of supported studies | Average coverage | |
---|---|---|---|
cardiac muscle cell | 6 studies | 63% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 5 studies | 27% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1534.04 | 89 / 89 | 79% | 13.55 | 709 / 901 |
brain | 85% | 230.66 | 2235 / 2642 | 94% | 4.01 | 660 / 705 |
ovary | 69% | 129.33 | 125 / 180 | 51% | 1.10 | 220 / 430 |
lung | 86% | 204.85 | 499 / 578 | 31% | 0.58 | 359 / 1155 |
breast | 79% | 202.89 | 362 / 459 | 38% | 0.73 | 430 / 1118 |
heart | 100% | 110932.11 | 861 / 861 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.31 | 1 / 1 |
muscle | 99% | 53685.26 | 793 / 803 | 0% | 0 | 0 / 0 |
spleen | 92% | 292.39 | 222 / 241 | 0% | 0 | 0 / 0 |
adipose | 90% | 211.45 | 1086 / 1204 | 0% | 0 | 0 / 0 |
uterus | 64% | 132.29 | 109 / 170 | 23% | 6.75 | 104 / 459 |
adrenal gland | 55% | 119.81 | 142 / 258 | 10% | 0.15 | 23 / 230 |
liver | 20% | 33.15 | 46 / 226 | 43% | 1.36 | 173 / 406 |
prostate | 33% | 309.78 | 81 / 245 | 24% | 4.95 | 122 / 502 |
skin | 34% | 73.19 | 607 / 1809 | 18% | 0.30 | 83 / 472 |
esophagus | 42% | 103.25 | 613 / 1445 | 7% | 0.12 | 13 / 183 |
blood vessel | 49% | 504.11 | 648 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 3% | 9.13 | 9 / 328 | 45% | 0.77 | 80 / 178 |
bladder | 33% | 53.10 | 7 / 21 | 14% | 0.23 | 69 / 504 |
thymus | 19% | 50.70 | 123 / 653 | 23% | 0.62 | 141 / 605 |
lymph node | 0% | 0 | 0 / 0 | 41% | 0.65 | 12 / 29 |
intestine | 24% | 40.05 | 235 / 966 | 11% | 0.35 | 60 / 527 |
stomach | 15% | 27.65 | 55 / 359 | 13% | 0.44 | 38 / 286 |
eye | 0% | 0 | 0 / 0 | 21% | 0.54 | 17 / 80 |
tonsil | 0% | 0 | 0 / 0 | 18% | 2.30 | 8 / 45 |
peripheral blood | 9% | 122.02 | 81 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006942 | Biological process | regulation of striated muscle contraction |
GO_0002026 | Biological process | regulation of the force of heart contraction |
GO_0032781 | Biological process | positive regulation of ATP-dependent activity |
GO_0060048 | Biological process | cardiac muscle contraction |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_0031674 | Cellular component | I band |
GO_0030017 | Cellular component | sarcomere |
GO_0005829 | Cellular component | cytosol |
GO_0005859 | Cellular component | muscle myosin complex |
GO_0016460 | Cellular component | myosin II complex |
GO_0031672 | Cellular component | A band |
GO_0032038 | Molecular function | myosin II heavy chain binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0003785 | Molecular function | actin monomer binding |
GO_0008307 | Molecular function | structural constituent of muscle |
Gene name | MYL3 |
Protein name | Myosin 1 light chain Myosin light chain 3 Myosin light chain 3 (Cardiac myosin light chain 1) (CMLC1) (Myosin light chain 1, slow-twitch muscle B/ventricular isoform) (MLC1SB) (Ventricular myosin alkali light chain) (Ventricular myosin light chain 1) (VLCl) (Ventricular/slow twitch myosin alkali light chain) (MLC-lV/sb) |
Synonyms | |
Description | FUNCTION: Regulatory light chain of myosin. Does not bind calcium. |
Accessions | ENST00000431168.2 ENST00000654597.1 Q14909 ENST00000395869.5 ENST00000292327.6 P08590 ENST00000662933.1 ENST00000431168.1 E9PGV7 ENST00000653454.1 A0A7R6M6R5 |